Targeting the gut microbiome: A new approach to treating diabetes

FHS
June 24, 2024
2:30 pm

Researchers review the role of gut microbiota in the pathogenesis and management of diabetes mellitus.

Injected form of Leqembi appears effective at clearing amyloid, but with notable risks

New data on an injectable form of Eisai’s Alzheimer’s drug Leqembi showed that it was more effective than an intravenous version at clearing amyloid, but

October 26, 2023

In historic decision, FDA approves a CRISPR-based medicine for treatment of sickle cell disease

The Food and Drug Administration on Friday approved the world’s first medicine based on CRISPR gene-editing technology, a groundbreaking treatment for sickle cell disease that

December 8, 2023

WHO publishes report introducing updated terminology for airborne pathogens

Following consultation with public health agencies and experts, the World Health Organization (WHO) publishes a global technical consultation report introducing updated terminology for pathogens that

April 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.